Background: Although HSV-2 is the major cause of genital lesions, HSV-1 accounts for
| INTRODUCTION
Herpes simplex viruses are members of the Alphaherpesvirinae subfamily within the Herpesviridae virus family. There are two serotypes of herpes simplex virus (HSV): HSV type 1 (HSV-1), which is more frequently found in the oral mucosa and ocular areas, and HSV type 2 (HSV-2), which is most commonly encountered as the causative agent of genital tract HSV infections. 1 HSV is a ubiquitous human pathogen, with worldwide prevalence rates approaching 90% for HSV-1 and up to 25% for HSV-2, depending on socioeconomic class. 2, 3 The virus contains a large, linear double-stranded DNA (dsDNA) genome of 150 kbp, and it is approximately 83% homologous between HSV-1 and HSV-2 in the coding regions. 4 HSV-1, which is usually transmitted in childhood through non-sexual contact, is the primary cause of orolabial herpes, but it can also cause genital infection. HSV-2, which is usually sexually transmitted, is an uncommon cause of orolabial herpes. Among Americans who are 14-19 years of age, the seroprevalence of HSV-1 has decreased by 30% over the past 30 years;
thus, an increasing proportion of adolescents lack protective HSV-1 antibodies when they become sexually active. 5, 6 This lack of HSV-1
antibodies has led to an increased frequency of HSV-1 genital herpes acquired from oral-genital sex practices. 7 In some populations (especially young heterosexual women who are 18-22 years of age, nonHispanic whites, and men who have sex with men [MSM]), HSV-1 is a more common cause of initial episodes of genital herpes than HSV-2. 8, 9 Young women and MSM are also at high risk of acquiring HIV infection, 10, 11 and although genital HSV-2 infection is associated with a threefold increase in the risk of acquiring HIV infection, 12, 13 nothing is know about the risk of HIV acquisition in the context of genital HSV-1 infection.
HSV-2 genital infection increases the risk of HIV infection even in
absence of detectable HSV-2 replication, lesions, or inflammation. 14 It was reported that the vaginal mucosa of HSV-2-infected women retains an increased number of CCR5 + CD4 + T cells long after HSV-2 replication abates. Likewise, plasmacytoid and myeloid dendritic cells (DCs), which infiltrate areas of skin infected with HSV-2, persist after lesion healing even in the context of acyclovir therapy. 15, 16 To study the mechanisms driving the increase in HIV infection due to HSV-2, we developed a model of HSV-2 infection in rhesus macaques. 17 This model was used to describe how HSV-2 infection can lead to sustained increase in local and systemic inflammatory mediators and increased availability of highly susceptible HIV target cells long after the primary infection abates (>1 year). [18] [19] [20] Primary HSV infection usually starts with virion attachment and replication into epithelial cells and keratinocytes at mucocutaneous sites including the mouth, eyes, and genitalia. HSV subsequently accesses the peripheral nervous system (PNS) where it can either initiate productive replication, which ultimately leads to destruction of the neuron, or to the establishment of latent infection. 21 Although humans are the only natural hosts for HSV-1 and HSV-2, mice have been used as preferred models to study the mechanisms of HSV infection and immune responses to the virus also because the mouse models mimic several aspects of the human disease. 22 
| METHODS

| Humane care guidelines
Three adult female Indian rhesus macaques (Macaca mulatta) with a mean age of 8 years, ranging from 6 to 10 years; and a mean weight of 8.5 kg, ranging from 7.2 to 10.85 kg were enrolled for these studies. was administered for procedures that may cause more than temporary pain or distress to provide preemptive and post-procedural analgesia.
| Macaque treatment
Three healthy SHIV-SF162P3-infected Indian rhesus macaques with undetectable SIV viral load were vaginally challenged twice using 
| HSV-1 detection
Total vaginal swabs, including both mucosal cells and fluid, were shipped overnight, cleared by centrifugation, aliquoted, and frozen as previously described. 17 DNA was extracted from the total swab using the DNeasy 
| Luminex
Cytokine and chemokine soluble factors were measured using 
| SHIV-SF162P3 detection
Plasma and cell-associated viral loads were monitored at baseline (BL) and at day 5, 12, and 20 post-HSV-1 infection. SIV plasma was isolated from EDTA blood by centrifugation and stored −80°C. Plasma viral RNA copies were measured by quantitative RT-qPCR for SIVgag, as previously described by Leidos Biomedical Research Inc. 32 The lower limit of quantification of the assay is 15 RNA copies/mL. 
| Flow cytometry
Fresh PBMCs were phenotyped at baseline (BL) and day 5 after the second inoculation. PBMCs were isolated using Ficoll-Hypaque density gradient centrifugation. Cells were stained with the LIVE/DEAD Aqua dye (Invitrogen), and the antibodies listed in Table 1 . Unlabeled anti-CD195 from the NIH AIDS repository was directly conjugated with AF647H-labeling kit (Innova Biosciences, Babraham, UK). At least 200 000 events were acquired in the lymphocyte live cells gate using the BD LSRII Flow Cytometer. Data were acquired using Diva software and analyzed using FLOwJO software.
| RESULTS
| Gentle cytobrushing before HSV-1 inoculation may be needed for genital HSV-1 infection of rhesus macaques
Three healthy SHIV-SF162P3-infected female rhesus macaques of 
| Impact of genital HSV-1 infection on SHIV-SF162P3 loads
Blood was collected at baseline (BL; day of the second inoculation/ HSV-1 infection) and day 5, 15, and 20 post-HSV-1 infection. Plasma SIV load was monitored by an RT-qPCR with a sensitivity of 15 copies/mL. The plasma VL of GM17, which had undetectable VL at baseline, remained undetectable throughout the monitoring phase, while both HV92 and JA87 had increased VL at day 12 compared to BL ( Figure 1C ). SHIV-SF162P3 was also undetectable in the vaginal biopsy of GM17 from both before and after HSV-1 infection (Figure 2) , while HV92 had similar amount of SHIV-SF162P3 DNA in tissue before and after HSV-1 infection. In contrast, JA87, which had intermittent HSV-1 shedding, had increased vaginal tissue SHIV-SF162P3 load on day 20 compared with BL ( Figure 2 ).
| Impact of genital HSV-1 infection on cytokines and chemokines in vaginal fluids
Cytokines and chemokines (CC/CK) from all three animals were moni- (Figure 3, top two rows) . In contrast, GM17, which had undetectable SHIV-SF162P3 VL in plasma and vaginal tissue, had very low levels of most CC/CK at BL and levels were mostly unchanged by HSV-1 infection. HV92 had only increased levels of factors involved in wound healing (such as HGF, FGF and G-CSF) and IL-6, also critical factor in skin wound healing 34 
| Impact of genital HSV-1 infection on the frequency of certain CD4 + T-cell subsets in blood
PBMCs from all three animals were isolated at BL and day 5 post-HSV-1 infection and stained with the antibodies listed in Table 1 .
Consistent changes in all three animals were seen only in the fre- 
| DISCUSSION
There are ~140 million people living with genital HSV-1 infections, and a growing number of young women and MSM are at high risk of acquiring genital HSV-1 in both developed and developing countries. 
